Edgestream Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8M Sell
3,752
-1,647
-31% -$843K 0.06% 522
2025
Q4
$3.03M Buy
5,399
+3,786
+235% +$2.15M 0.09% 420
2025
Q3
$829K Sell
1,613
-24,618
-94% -$10.7M 0.02% 656
2025
Q2
$8.23M Buy
26,231
+4,793
+22% +$1.44M 0.23% 132
2025
Q1
$6.53M Buy
21,438
+2,139
+11% +$720K 0.22% 154
2024
Q4
$6.41M Sell
19,299
-7
-0% -$2.37K 0.27% 85
2024
Q3
$6.44M Buy
19,306
+6,235
+48% +$2.37M 0.28% 82
2024
Q2
$5.38M Buy
+13,071
New +$5.18M 0.26% 105
2024
Q1
Sell
-1,750
Closed -$536K 940
2023
Q4
$536K Sell
1,750
-3,647
-68% -$984K 0.04% 596
2023
Q3
$1.31M Buy
+5,397
New +$1.38M 0.1% 312
2023
Q2
Sell
-9,937
Closed -$1.87M 832
2023
Q1
$1.87M Buy
+9,937
New +$2.06M 0.21% 161

Other funds holding MEDP

Edgestream Partners's MEDP Position: Q1 2026 in Review

Edgestream Partners reduced its Medpace (MEDP) stake by 31% in Q1 2026, selling an estimated $843K and leaving 3,752 shares worth $1.8M. The position accounts for 0.06% of the portfolio, ranked #522.

Edgestream Partners first reported a position in MEDP in Q1 2023 and has held it in 11 quarters since. The position peaked at $8.23M in Q2 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Edgestream Partners held 3,752 shares of Medpace worth $1.8M as of Q1 2026.
  • Edgestream Partners sold 1,647 Medpace shares in Q1 2026, an estimated $843K.
  • Medpace made up 0.06% of Edgestream Partners's portfolio in Q1 2026, its #522 holding.
  • Edgestream Partners first reported a position in Medpace in Q1 2023 and has held it in 11 quarters since.
  • Edgestream Partners's Medpace position peaked at $8.23M in Q2 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.